1. Home
  2. TCOM vs BNTX Comparison

TCOM vs BNTX Comparison

Compare TCOM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trip.com Group Limited

TCOM

Trip.com Group Limited

HOLD

Current Price

$41.39

Market Cap

25.7B

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$93.67

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCOM
BNTX
Founded
1999
2008
Country
Singapore
Germany
Employees
43574
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.7B
24.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TCOM
BNTX
Price
$41.39
$93.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
13
Target Price
$78.75
$133.46
AVG Volume (30 Days)
3.8M
966.0K
Earning Date
05-18-2026
05-05-2026
Dividend Yield
0.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.73
N/A
Revenue Next Year
$13.00
$3.37
P/E Ratio
$9.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.04
$79.81
52 Week High
$79.00
$124.00

Technical Indicators

Market Signals
Indicator
TCOM
BNTX
Relative Strength Index (RSI) 36.91 52.96
Support Level $38.04 $90.95
Resistance Level $54.81 $94.20
Average True Range (ATR) 1.34 2.31
MACD -0.10 0.52
Stochastic Oscillator 36.59 46.62

Price Performance

Historical Comparison
TCOM
BNTX

About TCOM Trip.com Group Limited

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: